Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Bioanalytics
Keynote

Keynote: Harnessing MALDI Mass Spectrometry Imaging for Biomarker Development in Hepatocellular Carcinoma Diagnosis and Prognosis

Tuesday, November 11, 2025
1:30 PM - 2:30 PM CT
Location:221 CD

Bioanalytics

    Keynote Speaker(s)

  • Anand Mehta, DPhil (he/him/his)

    Senior Associate Dean for Research and Professor
    Medical University of South Carolina
    Charleston, South Carolina

    Handouts

    • Moderator(s)

  • Jim Shen, PhD

    Executive Director, Head of Regulated Bioanalysis and Mass Spectrometry
    Bristol Myers Squibb
    Princeton, New Jersey

In this presentation, the use of MALDI Mass Spectrometry Imaging to identify biomarkers of hepatocellular carcinoma will be discussed. Additionally, we will explore how this fundamental technique has been modified to enable high-throughput analysis of proteins and cells.

Learning Objectives:

  • Learn about the method of MALDI MSI – which a is powerful tool for Biomarker discovery
  • Learn about N-linked glycosylation and its potential use a biomarker of health.
  • Learn how we developed novel tools for the simultaneous and rapid analysis of 1000’s of proteins or cells.